Xytex Sperm Bank Lawsuit: Donor Fraud, Rulings, and Insurance

The Xytex sperm bank lawsuits are a wave of more than a dozen fraud, negligence, and consumer protection cases filed since 2014 by families in the United States, Canada, and elsewhere who say the Georgia-based company sold them sperm from a donor it marketed as a healthy PhD candidate with a 160 IQ but who was actually a college dropout with schizophrenia, bipolar disorder, and a burglary conviction. Georgia courts have dismissed most of the claims under the state’s ban on “wrongful birth” suits, though a 2020 Georgia Supreme Court decision left a narrow path open, and no case has publicly reached a trial verdict or disclosed settlement.¹

The Donor Marketed as a Genius

At the center of the litigation is one man: James Christian Aggeles, catalogued by Xytex as Donor 9623. Over a 14-year relationship with the company, he fathered at least 36 children through sperm donation.²

Xytex marketed him as one of its best donors. His profile described him as “ultra intelligent,” a man of “high integrity” pursuing a doctorate in neuroscience engineering, with an IQ of 160.³ A Xytex employee, Mary Hartley, allegedly coached Aggeles during the application process, telling him his IQ was “probably 160” despite his own estimate of 130, because sperm from highly educated donors sold better.⁴

The real Aggeles looked nothing like the profile. When he began donating he was a college dropout working as a janitor and waiter.⁵ He had been hospitalized twice in 1999 for mental illness and diagnosed with schizophrenia, bipolar disorder, and narcissistic personality disorder. By 2002 he was on disability. In 2005 he pleaded guilty to residential burglary and served several months in jail.⁶ The lawsuits allege Xytex continued selling his sperm even after his criminal history and mental illness became known to the company.⁷

How Families Found Out

The deception unraveled differently for different families. Angela Collins and Margaret Elizabeth Hanson, a couple in Port Hope, Ontario, learned the donor’s real name in June 2014 after Xytex accidentally copied Aggeles on an email sent to a recipient family. A quick online search revealed his criminal record.⁸

For Wendy and Janet Norman, a Georgia couple, suspicion began when their son, born in 2002, inherited a genetic blood disorder for which Wendy was not a carrier. That led them to investigate Donor 9623’s actual background.⁹ Other families only learned the truth from news coverage of the Collins lawsuit. When one family confronted Xytex, a company agent said they were unaware of “any reported medical issues,” and the chief medical director called the allegations “unsubstantiated.”⁵

How Many Families Have Sued

By mid-2016, at least 13 lawsuits had been filed against Xytex in the United States, brought by 14 parents or sets of parents across four states.¹ More followed in Canada. In April 2016, three Ontario families sued Xytex and its Canadian distributor, Outreach Health Services, in Newmarket, seeking C$15.4 million.¹⁰ Two British Columbia families filed claims in B.C. Supreme Court against Xytex, Vancouver’s Genesis Fertility Centre, and Mary Hartley, seeking damages for fraud, negligence, and the cost of monitoring their children’s mental health.⁸

The claims across cases were consistent: fraud, negligent misrepresentation, product liability, and violations of consumer protection laws. A later consolidated Georgia case, A.D.A. v. Xytex Corporation, also swept in families connected to two other donors. Donor 3116 was described as a cytogeneticist with no genetic abnormalities but was allegedly a lab technician with Charcot-Marie-Tooth disease. Donor 5444 was allegedly represented similarly but had symphalangism, a condition causing fused finger joints.¹¹

Why Georgia Courts Keep Dismissing the Claims

The families’ central obstacle has been Georgia law. Courts in the state do not recognize “wrongful birth” as a cause of action. A plaintiff cannot recover damages premised on the argument that a child should not have been born. Every time a family alleged they would not have bought the sperm had they known the truth, Georgia courts treated the claim as wrongful birth and dismissed it.

The first Georgia case, brought by Collins and Hanson, was dismissed at the trial court on that basis, and an appeal was rejected on procedural grounds.¹⁰ Rene and Trayce Zelt then filed suit in federal court raising 13 state-law claims. In February 2019, the U.S. Court of Appeals for the Eleventh Circuit affirmed the dismissal of every claim, acknowledging that Xytex’s alleged conduct was “reckless, reprehensible, and repugnant” but concluding it could not extend Georgia law to treat the birth of a child with inherited traits as a legal injury.¹²

What the Norman Ruling Changed

The Georgia Supreme Court reshaped the landscape in September 2020 with Norman v. Xytex Corp. The court drew a line prior rulings had not: while claims premised on the child’s existence as an injury remained barred, families could pursue claims for damages that did not flow from the child’s birth.¹³

The court identified three theories that could survive:

Consumer fraud claims under Georgia’s Fair Business Practices Act for misrepresentation of the quality of goods and services.
Economic damages equal to the difference between what a family paid and the fair market value of sperm matching the profile they were promised.
Medical harm claims alleging that Xytex’s failure to share the donor’s medical history delayed a child’s diagnosis or worsened a condition.¹³

The Norman case was sent back to the trial court to determine whether the family’s specific allegations fit those surviving categories. As of a June 2021 appellate ruling, the case was still at the motion-to-dismiss stage.¹⁴

The 2026 Appellate Setback

The roadmap Norman laid out proved hard to follow. On February 5, 2026, the Georgia Court of Appeals unanimously affirmed the dismissal of all claims in A.D.A. v. Xytex Corporation, a consolidated case brought by 23 parents connected to Donors 3116, 5444, and 9623.¹¹

Writing for the court, Presiding Judge Brian Rickman found that every one of the plaintiffs’ 13 causes of action still incorporated the allegation that the parents would not have purchased the sperm had they known the truth. That, the court held, was “the prohibited wrongful birth claim” the Supreme Court had warned against in Norman.¹⁵ The plaintiffs, the court said, had not isolated claims or damage theories that could survive without relying on the child’s existence as the injury, and the court would not act as an “advocate” to reformulate their arguments. Judges Gobeil and Davis concurred; there were no dissents.¹¹

Xytex’s Insurance Won’t Cover the Cases

Xytex’s legal exposure grew in December 2024, when U.S. District Judge Thomas Thrash ruled in Allied World Surplus Lines Insurance Co. v. Georgia Cryoservices, Inc. that Allied World had no duty to defend or indemnify Xytex in any of the underlying lawsuits, including the Canadian actions and the Georgia cases.¹⁶ The court determined that emails sent by families of Donor 3116 to Xytex in April and May 2019 were “written demands seeking monetary damages,” which qualified as claims under the policy. Because those demands predated the policy’s March 2020 start date, the claims fell outside the coverage period.¹⁷

What Screening Xytex Actually Did

The lawsuits exposed how little the fertility industry verifies about donors. Xytex’s website acknowledges that donor-reported medical history is “not validated” by reviewing the donor’s personal medical records or those of his family.¹⁸ When Aggeles was donating, the screening process consisted of a questionnaire and a brief physical exam during which his mental health history was never discussed.⁵

For donors entering its program after 2017, Xytex says it now requires background checks, education verification, personality and behavioral evaluations, and psychosocial assessments conducted by a licensed clinical psychologist and a social worker.¹⁹ Those safeguards did not exist when Aggeles was accepted.

Federal regulation is narrow. The FDA requires donor screening and testing for communicable diseases and quarantine of specimens until testing is complete.²⁰ There is no federal requirement for criminal background checks, independent verification of a donor’s education or medical claims, or a cap on the number of children per donor.⁶

Where Things Stand Now

As of early 2026, no public reporting indicates that any of the Xytex donor lawsuits in the United States or Canada have gone to trial or produced a publicly disclosed settlement. The February 2026 A.D.A. ruling leaves the Norman door open in theory, but the courts have made clear that plaintiffs must plead their claims with precision, isolating harms that do not depend on treating a child’s birth as the injury. Xytex has denied wrongdoing throughout the litigation and maintains that it complies with industry standards.¹⁰

1
Courthouse News Service. More Legal Fallout From Semen Donor 9623
2
GPB News. Georgia Supreme Court Rules Sperm Donor Case Falls in Line With Consumer Fraud
3
The Atlantic. The Sperm Donor Problem
4
ALM. A.D.A. v. Xytex Brief of Appellant
5
Tushnet.com. False Advertising of Sperm Donor Leads to Wrongful Birth Claim
6
Atlanta Magazine. Georgia Sperm Bank Troubled Donor and the Secretive Business of Babymaking
7
Regulations.gov. Canadian Class Action Filing Regarding Xytex Donor 9623
8
CBC News. Sperm Donor Aggeles Xytex Mistake
9
The Conversation. Sperm Donation Is Largely Unregulated but That Could Soon Change as Lawsuits Multiply
10
The Guardian. Sperm Donor Canada Families File Lawsuit
11
ALM. A.D.A. v. Xytex Corporation, A25A1544
12
Law.com. Zelt v. Xytex, No. 18-11164 (11th Cir.)
13
CCH. Norman v. Xytex Corp., No. S19G1486
14
FindLaw. Norman v. Xytex Corp., Court of Appeals of Georgia
15
Law.com. Sperm Bank Fraud Claim Dismissal Upheld on Appeal
16
Insurance Journal. Allied World Not Required to Defend Xytex in Wrongful Birth Suits
17
Insurance Journal. Allied World v. Georgia Cryoservices Order
18
Xytex. Donor Screening Process
19
Xytex. First Steps Xytex Canada
20
FDA. What You Should Know About Reproductive Tissue Donation